Axons from patients with PARK2 PD showed a ~1.5-fold reduction in cGFP fluorescence recovery (Fig. 5, A and B) and a significant reduction in their mobile fraction compared to healthy controls (Fig. 5C). Here, PRKN is linked to Parkinson disease.